TRIM29 and Dilatation of the cerebral artery: tRF-AspGTC promotes vascular smooth muscle cell (VSMC) phenotypic conversion and inflammatory responses by inhibiting Tripartite motif-containing protein 29 (TRIM29, a Protein Coding gene)-mediated galectin-3 ubiquitination, thereby activating the TLR4/MyD88/NF-κB signaling pathway and ultimately contributing to intracranial aneurysm (IA) formation [87].